Debra Fleischman to Radiopharmaceuticals
This is a "connection" page, showing publications Debra Fleischman has written about Radiopharmaceuticals.
Connection Strength
0.028
-
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease. Curr Alzheimer Res. 2014; 11(6):564-73.
Score: 0.028
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.